Resource Library

Whitepapers

Establishing Turnkey Tech Transfer Processes For Drug Product

Establishing_turnkey_tech_transfer_processes_for_drug_product.png

A well-planned tech transfer is vital for the Drug Product (DP) manufacturing process to start off on the right foot. As a trusted CDMO partner, Samsung Biologics drives its clients’ development and commercialization efforts through a diverse toolkit and operational agility, accommodating projects of varying scale with speed and flexibility in ensuring a sterile final product. In this whitepaper, Brian Bayly, our Head of DP MSAT, presents how our end-to-end capability provides clients with the expertise, experience, and infrastructure to support aseptic production, all while maintaining top quality and full regulatory compliance.

Establishing_turnkey_tech_transfer_processes_for_drug_product.png

A well-planned tech transfer is vital for the Drug Product (DP) manufacturing process to start off on the right foot. As a trusted CDMO partner, Samsung Biologics drives its clients’ development and commercialization efforts through a diverse toolkit and operational agility, accommodating projects of varying scale with speed and flexibility in ensuring a sterile final product. In this whitepaper, Brian Bayly, our Head of DP MSAT, presents how our end-to-end capability provides clients with the expertise, experience, and infrastructure to support aseptic production, all while maintaining top quality and full regulatory compliance. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION